Chinese robotics giant Unitree soars in stock market debut
Shares in the world's biggest humanoid robot maker started trading on Shanghai's Star market on Wednesday.

Chinese robotics powerhouse Unitree experienced a remarkable stock market debut in Shanghai on Wednesday, with its shares surging over 600%. The company, renowned as the world's largest producer of humanoid robots, saw its shares open at 1,100 yuan (£120.60; $163.12) in its highly anticipated initial public offering (IPO), significantly surpassing the offer price of 150.8 yuan.
This listing on the tech-focused Star Market, often referred to as China's Nasdaq, represents a pivotal moment for Beijing's ambitious strategy to advance its domestic robotics industry. The event unfolds amidst a global competition between the US and China to dominate the market for robots and the artificial intelligence (AI) models that power them.
While automated industrial equipment and smart vacuum cleaners are already prevalent in factories, warehouses, and homes, the humanoid robotics sector is now attracting substantial investment. Major corporations such as Tesla, BYD, and Amazon are actively developing bipedal machines designed to perform tasks typically carried out by humans.
Established in 2016, Unitree has emerged as a leader in the robotics industry, offering a diverse range of products from sensors and automated arms to quadrupedal and human-like machines. For several years, the company has been a formidable competitor to US developers, introducing robots with comparable features at more accessible price points.
Based in Hangzhou, eastern China, Unitree plays a crucial role in Beijing's aspiration to lead in cutting-edge technologies. This region is home to a "golden cluster zone" of robotics firms, which have benefited from significant government investments. According to the state-run China Daily, this support contributed to a more than threefold increase in the number of Chinese robotics firms between 2020 and 2024.
Robots are also viewed as a potential solution to the challenges posed by China's aging population, which is projected to lead to a shortage of workers for the economy's physically demanding manufacturing base, as noted by Fei Qin, an associate professor at the University of Bath. Qin emphasized that Beijing considers the robotics sector a "strategic priority" in its pursuit of advanced technology leadership, stating that "Robots are where AI leaves the screen and enters the economy" in factories, hospitals, and potentially homes.
Harold Soh, a researcher from the National University of Singapore, observed that while US robots often feature more user-friendly software, the lower prices offered by Chinese manufacturers are difficult to overlook. Unitree's robot dogs, for instance, start at $2,700, a fraction of the approximately $70,000 price tag for Boston Dynamics' four-legged device, Spot. Soh clarified that while "They're not exactly comparable because some of Unitree's dogs are much smaller," the "price is a big difference."
Unitree began selling humanoid robots in 2023, with its $13,500 child-sized G1 model launching the following year. In contrast, major US competitors, including Elon Musk's Tesla, have yet to commence deliveries of rival products.
The G1 and other Unitree robots have been central to an extensive marketing campaign preceding the firm's IPO. This week, Unitree's machines are participating in the 2026 World Humanoid Robot Games in Beijing, an event featuring hundreds of teams competing in activities such as running, football, box opening, and sorting library books. Earlier this year, Unitree's G1 robots garnered public and research attention with a martial arts display during China's Spring Festival Gala. Robotics researcher David Hsu noted that the event, broadcast on state TV in February, showcased the robots performing a "full range of motions, live on stage, in a way we'd never seen before," indicating "a rise of an industry."
Some experts view Unitree's market debut as an indicator of investor interest in the rapidly expanding humanoid robotics sector. Jack Pearson from investment firm RoboStrategy stated that the listing offers the public a rare opportunity to invest in a humanoid robotics company and could establish a benchmark for other manufacturers. Pearson also highlighted the listing as a "turning point" for China's robotics industry, noting Unitree's success despite US restrictions on foreign-made robot imports.
Unitree's IPO follows almost three years after its smaller Chinese rival, UBTech Robotics, listed on the Hong Kong stock market. In July of this year, UBTech attracted global attention by unveiling what Chinese state media described as a "life-sized, hyper-realistic humanoid robot designed as a companion that offers users emotional support and everyday interaction." More robot manufacturers, including Leju Robotics and AgiBot, are anticipated to follow UBTech and Unitree with stock market listings in the coming months.
However, this industry optimism is tempered by some experts' doubts regarding demand for robots outside of industrial and commercial applications. Soh believes that robots are still years away from effective operation in homes, citing the need for developers to address issues such as longer battery life, privacy safeguards, and reliability. He anticipates the initial market will be for robots used in environments like factories and hospitals.
Robots and AI have become the latest point of contention in the US-China rivalry, with both nations considering them strategically important industries. In July, the administration of US President Donald Trump announced a ban on new Chinese-made humanoid and quadruped robots, citing national security concerns and the protection of US manufacturing. Beijing rejected this claim, accusing Washington of "politicizing" trade issues. The White House has also imposed stringent restrictions on other Chinese technologies, including AI models, electric cars, semiconductors, and drones.
Christine Wan from the Peterson Institute for International Economics noted that China's dominance in the robotics industry underscores a broader challenge for Washington as Chinese firms become more "deeply embedded" in global manufacturing. Wan suggested that "Other countries may be reluctant to sharply reduce their reliance on Chinese suppliers if doing so would significantly disrupt domestic manufacturing."
So far, Western robots have not achieved the same impact on factory floors or in the consumer market. Boston Dynamics, a prominent US robotics developer, has announced plans to deploy human-like machines in car maker Hyundai's factories within two years. The South Korean firm acquired a majority stake in Boston Dynamics in 2021. Other US companies, such as Amazon and Tesla, have also revealed intentions to integrate humanoid robots into their operations. Earlier this year, Musk's firm stated it would utilize its California manufacturing plant, which produced Model S and X cars, to produce its line of Optimus humanoid robots. Amazon, which piloted the use of humanoid robots in its warehouses in 2023, informed the BBC that it has completed a pilot scheme for the technology and is continuing its research into next-generation robotics. The BBC has also reached out to Tesla and Boston Dynamics for comments on their humanoid robot plans.
Hsu emphasized that the US has relinquished the lead in robotics it held a decade ago. "We no longer hear about American robotics companies in the news. It's the Chinese robot companies that are making news today," he stated, adding, "They have replaced America as the cool kids on the block."

